Skip to content

A comparative study of ultrasound-guided rhombus-intercostal-serratus anterior serratus low-level nerve block and quadratus lumbar nerve block on rapid recovery after laparoscopic nephrectomy

A comparative study of ultrasound-guided rhombus-intercostal-serratus anterior serratus low-level nerve block and quadratus lumbar nerve block on rapid recovery after laparoscopic nephrectomy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087175
Enrollment
Unknown
Registered
2024-07-22
Start date
2023-06-19
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney tumors

Interventions

The group of rhomboid-intercostal-serratus anterior serratus plane nerve block :10ml of ropivacaine with 0.375% concentration was injected into the rdiamond-intercostal muscle plane, and 20ml of ropiv
The group of quadratus lumbosus plane nerve block:30ml of 0.375% ropivacaine was injected into the quadratus lumbosus plane

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The first patient who intends to undergo laparoscopic nephrectomy every day 2. Male or female, 18~65 years old 3. Body mass index (BMI) of 18.5-28 4.ASA?~? 5. Cardiac function grading NYHA I-II 6.Those who can voluntarily sign the informed consent form and cooperate with the research process

Exclusion criteria

Exclusion criteria: 1. Those who cannot communicate normally and cannot cooperate with VAS scoring and questionnaire surveys; 2. Patients with other major diseases; 3. Infection at the puncture site; 4. Chest and back deformities can not carry out nerve block, 5. Left ventricular ejection fraction less than 40%, cardiopulmonary insufficiency 6. Have a history of local anesthetic allergy 7. Those with serious surgical complications

Design outcomes

Primary

MeasureTime frame
Sufentanil consumption 24 hours after surgery;

Secondary

MeasureTime frame
Visual Analogue Scale;serum cortisol(COR);Serum interleukin 6;Postoperative quality of recovery (Qor-15);Intraoperative heart rate (HR) and mean arterial pressure (MAP);

Countries

China

Contacts

Public ContactJia Min

The First Affiliated Hospital of Nanchang University

candymin66@163.com+86 139 7089 9291

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026